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COVID-19 is an ongoing pandemic and all age groups are affected by SARS-CoV-2. Past studies showed that 
children are less affected by it and symptoms are quite variable as compared to adults. Multisystem Inflammatory 
Syndrome in Children (MIS-C) and Kawasaki-like illness are observed along with COVID-19 associated multi-
organ failure, acute respiratory distress syndrome (ARDS), and coagulopathy in the paediatric age group. 
Thrombotic complications in patients with COVID-19 have variable presentation including venous 
thromboembolism and ischemic complications related to thrombosis of extremity, cerebral, coronary, and distal 
arteries. Early recognition of acute limb ischemia and treatment can help to reduce mortality and maximize the 
chance of limb salvage. Here, we report a case of 11 years old child who developed gangrene of bilateral lower 
limbs after mild COVID-19 illness that ended in below-knee amputation. 
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Introduction 
 
COVID-19 pandemic continues to be a major threat to 
the human population worldwide. The causative 
organism is a novel virus, belongs to the family 
coronaviridae, and is named after severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2).1 
Virus is first found in the city of China in December 
2019.2 Disease course in children is comparatively 
milder than seen in adults due to some reasons yet to 
be determined. A recent study conducted in China to 
assess the burden of the severity of disease among 
different age groups in children showed the highest 
rate in infants (10.6%) followed by the age group from 
1-5 years (7.3%).3 According to a study done in France, 
a significant proportion of previously healthy patients 
(30%) encountered lethal manifestation of COVID-19.4 
Here, we present a case of an eleven years old child 
who presented with limbs discoloration (a rare 
presentation), which was later diagnosed as dry 
gangrene post-COVID-19 infection and ultimately led 




An 11-year-old male child, presented to the Pediatric 
Emergency Department of Holy Family hospital, 
Rawalpindi in January 2021, with complaints of bluish 
discoloration of legs for the last 3 days which was 
associated with severe pain and inability to walk. The 
patient further gave a history of fever and sore throat 3 
weeks back which got settled after few days without 
medication. The patient denied any history of hospital 
admissions in the past. All his family members were 
alive and healthy. There was no history of traveling for 
the last 2 weeks. On physical examination, his vitals 
were; temperature: 99o F, heart rate: 92/min, 
respiratory rate: 30/min, and blood pressure: 
100/70mmHg. Lower limbs examination showed 
bluish-black discoloration of left lower limb till mid-
calf and bluish discoloration of right lower limb till 
lower calf, and there was a line of demarcation present 
over the left lower limb. Pulses including dorsalis 
pedis and posterial tibial arteries were not palpable 
bilaterally and the rest of the systemic examination 
including the respiratory system was unremarkable. 
 
 
Figure 1: Gangrene of lower limbs before below-
knee amputation 
 
Laboratory investigations were done and showed 
leukocytosis: 29.2×109 (normal reference range: 4.0-
10.0×109) with neutrophilia: 91.9% (normal reference 
range: 40-80) and lymphopenia: 4.8% (20-40), CRP was 
68 (0-6) and ESR was also high, 80 (0-15mm/hour). 
Coagulation screening showed PT 15secs (10-16), aPTT 
38secs (24-39) and D-Dimers 0.8mg/L (normal below 
0.5). Chest X-ray was normal and ECG showed a 
normal sinus pattern. Arterial doppler revealed absent 
flow in distal, anterior tibial, posterior tibial, and 
dorsalis pedis arteries. Venous doppler showed no 
evidence of deep vein thrombosis. The patient was 
managed empirically with broad-spectrum antibiotics, 
low molecular weight heparin, and pain killers. 
Echocardiography was unremarkable with no 
evidence of intracardiac thrombus. The thrombophilic 
screening was advised keeping in view congenital 
thrombophilia which showed antithrombin III 98% 
(85-122), protein C 81% (72-160), and protein S 74% 
(60-150). Serum ANA levels of 0.43 (normally less than 
0.83) broadly excluded autoimmune vasculitis in this 
patient. RT-PCR for SARS-CoV2 was sent keeping in 
view variable presentation of COVID-19, but it turned 
out to be negative so COVID-19 serology was 
performed and Immunoglobulin G levels were 
positive: 3.91 (negative <1.0). CT Angiography further 
confirmed almost complete stenosis of bilateral 
anterior tibial and posterior tibial arteries with 
collateral vessel formation. 
Despite management with anticoagulants and steroids, 
the patient developed gangrene of both limbs, and a 
line of demarcation of the right leg also appeared on 
day-5 of admission. Surgical consultation was done 
and the fate of the patient was decided in terms of 
below-knee amputation. The patient was discharged 
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on warfarin after bridging with heparin. The patient 
was monitored serially with INR and one month after 
discharge, no further evidence of thrombotic event 




COVID-19 infection is less prevalent in children but 
this age group is equally susceptible to this infection.5 
According to Chinese data, Pediatric COVID-19 cases 
are less severe as compare to adults but children have 
presented with variable symptoms than do adults.6 
Common signs and symptoms in children vary from 
myalgia, sore throat, fever, runny nose, headache, 
tachypnea, to gastrointestinal complaints of diarrhea 
and vomiting. Other manifestations include 
coagulopathy, shock, renal failure, and cardiac 
dysfunction. Multisystem Inflammatory Syndrome in 
Children (MIS-C), a term recently introduced in 
pediatric age group in which patient presents with 
mild inflammation to multi-organ failure and shock.7 
 Being a hypercoagulable state, it can present with 
variable manifestations including peripheral arterial 
infarcts to pulmonary thromboembolism despite 
adequate anticoagulation.8 The underlying pathology 
behind this state is quite complex as viruses can 
initiate coagulation cascade and trigger cytokines 
production by activation of monocytes and 
macrophages. These phenomena are being called 
immuno-thrombosis.  The disruption in normal 
antithrombotic property of endothelial cells and 
activation of the complement cascade can lead to 
possible complications associated with COVID-19.9  
A case study from Iraq highlighted this complication 
in an adult patient with no comorbidities.10 Iran-based 
studies proposed antithrombotic prophylaxis in 
children with COVID-19 which states that patients 
with mild COVID-19 should be kept under monitoring 
with coagulation markers keeping in view that some 
adult patients with mild symptoms had a worsening 
disease course afterward.9 Our case is unusual in 
terms of its presentation and disease course as mild 
COVID-19 cases are seldom seen with complications. 
Our patient also presented late as gangrene of one 
limb was already established at the time of 
presentation and eventually, amputation had to be 
done. To our knowledge, no case has been reported 
from the paediatric age group being affected by 
COVID-19 associated coagulopathy from Pakistan. A 
case report has been written after taking consent from 




Though the spectrum of COVID-19 is different in 
children, its associated complications are as lethal as 
seen in adults. Our patient developed gangrene due to 
arterial thrombosis after mild infection, so mild 
COVID-19 cases can present later with serious 
complications. Effective monitoring and timely 
intervention of patients with COVID-19 associated 
coagulopathy is the key to improve the outcome. 
Health professionals should also have a high suspicion 
of COVID-19 in such a case, particularly during this 
global pandemic.  
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